Cigna Gambit for Anthem Documents Runs up Against Big Blue Defense

A federal judge in Alabama deferred ruling whether to allow Cigna to access critical documents related to Blue Cross Blue Shield Association internal deliberations, just as Cigna’s bid infeatured

Cigna “End Run” in Anthem Suit Riles Federal Judge

Anthem urged a federal judge in Alabama Thursday to block efforts by Cigna to obtain key internal documents that may betray Anthem’s defense in a class action suit alleging the 50-statefeatured

Cigna Seeks Confidential Blues Documents in Anthem Fight

A federal court has temporarily blocked Cigna from obtaining board minutes from the various Blue Cross and Blue Shield plan sponsors who claim that the documents have been ruled confidential infeatured

Court Order Could Tip Delaware Case in Abbott’s Favor

Last Friday’s ruling by a federal court in Washington, D.C., against Alere’s Arriva Medical subsidiary could help persuade the Delaware Chancery Court to allow Abbott Laboratoriesfeatured

Corrected: Judge Promises to Protect Alere from Impending Drop-Dead Date

Revised at 1:56pm EST – The Delaware Chancery Court has set aside six days at the end of April for a trial to determine whether Abbott Laboratories can walk away from its acquisition of Alere, which would brush upfeatured

Judge Plans April Trial Over Alere/Abbott Break-Up

A Delaware judge rejected pleas by Alere Inc. to schedule a fast trial over the company’s efforts to salvage its $5.8 billion acquisition by Abbott Laboratories, siding instead with Abbott’s request for an April court date. Alere had asked the court for an expedited trial beginningfeatured

Abbott Says Suit Not Aimed at Breaking Alere Deal

Abbott Laboratories said a new suit seeking confidential legal and regulatory information from Alere is not an attempt to break the companies’ $5.4 billion merger, even as the companies accelerate toward a January court date that could do just that. “The objective of the (new) lawsuit is to obtain important information before the transaction is … Read Morefeatured

Abbott and Alere Move Toward Trial

Lawyers for Abbott Laboratories and Alere prepared for trial last week, even as the two companies continued to work with a court-ordered mediator to resolve differences over the $5.8 billion merger agreement. The Delaware Chancery Court set schedules last week requiring thatfeatured

Judge Could Give Go Ahead to Alere Merger Suit

A Delaware judge is expected to clear the way for Alere to pursue its suit compelling Abbott Laboratories to speed its work obtaining regulatory approvals for its $5.8 billion acquisition of Alere. Both companies have asked Vice Chancellor Samuel Glasscock to lift a September 2 stay on the suit and allow the companies tofeatured

Abbott and Alere Slow to the Mediation Table

More than two weeks after a state judge directed the two sides to resolve their differences over their merger pact, Abbott Laboratories and Alere Inc. are still unable to agree to a mediator, increasing the likelihood that the troubled deal goes back to court. Abbott recently proposed two former Delaware judges to mediate, but Alere … Read Morefeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.